TEX44

Across TCGA pan-cancer cohorts, TEX44 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of TEX44’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where TEX44 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types TEX44 is over-expressed in tumor, although a few such as KIRC show the opposite, repressed pattern.

BRCA, UCEC, and KIRC are the cancer types where TEX44 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in TEX44 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	Female	II,III,IV	+0.050	.014	4	view →
UCEC	All	IV	+0.285	.014	2	view →
KIRC	Male	II,III,IV	−0.007	.039	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

TEX44–BRCA

Open the BRCA breakdown →